Igovomab diagnostic agent - CIS Bio InternationalAlternative Names: INDIMACIS 125; OC 125 F(ab')2 - DTPA 111In
Latest Information Update: 17 Aug 2015
At a glance
- Originator CIS bio international
- Class Antineoplastics; Heavy metals; Imaging agents; Monoclonal antibody diagnostics; Radiopharmaceutical diagnostics
- Mechanism of Action Immunomodulators; Radionuclide imaging enhancers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Ovarian cancer